Syndromic Multiplex Panels Global Market Report 2023: Sector Continues to Expand With Players Reporting Double Digit Growth

News provided by

Jan 20, 2023, 12:50 ET

DUBLIN, Jan. 20, 2023 /PRNewswire/ -- The " Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, Gi Etc.) by Place, by Product and by Country. With Market Analysis, Executive Guides and Customization. " report has been added to ResearchAndMarkets.com's offering.

The COVID pandemic has ushered in a new world of infectious disease diagnostics. Infectious disease Dx is changing and will change more in the future. Can a rapidly growing market expand even faster?

Find out all about it in this comprehensive report on Syndromic Multiplex Diagnostics.

Are targeted tests for specific pathogens going to be obsolete? Will diagnostics replace physicians? Will Infectious Disease testing move into the Physician's Office or even the Home?

Syndromic testing is proving itself in the market. Players are reporting double digit growth. Lowering costs, improving outcomes and even helping in the battle against Anti Microbial Resistance. Learn about this market including the issues and outlooks. The two key trends of Point of Care Testing and Molecular Diagnostics are merging with spectacular success. It could possibly displace most frontline test protocols AND save money at the same time. The report forecasts the market size for five years. In a special section, the report looks at the numbers on how syndromic molecular diagnostics is replacing traditional panel based ordering of infectious disease tests.

Make investment decisions and valuations with confidence using the latest data.

The report includes five-year market forecasts.

Key Topics Covered:

1 Market Guides
1.1 Situation Analysis
1.2 Guide for Executives and Marketing Staff
1.3 Guide for Investment Analysts and Management Consultants

2 Introduction and Market Definition
2.1 What are Syndromic Multiplex Tests?
2.2 Syndromic Testing - the quiet revolution in diagnostics
2.2.1 Syndromic Testing - more than Panels
2.3 Market Definition
2.3.1 Multiplex Market Size
2.3.2 Currency
2.3.3 Years
2.4 Methodology
2.4.1 Authors
2.4.2 Sources
2.5 Perspective: Healthcare, the IVD Industry, and the COVID-19 Pandemic
2.5.1 Global Healthcare Spending
2.5.2 Spending on Diagnostics
2.5.3 Important Role of Insurance for Diagnostics

3 The Infectious Diseases - Guide to the Pathogens

4 Industry Overview

5 Market Trends
5.1 Factors Driving Growth
5.1.1 Speed of Diagnosis.
5.1.2 Effect of Syndromic Testing on Costs
5.1.3 Point of Care Advantage
5.1.4 Syndrome Testing, Accuracy and Diagnostic Risk
5.1.5 Single Visits
5.1.6 Improvement in Outcomes
5.1.7 Impact of the COVID-19 Pandemic
5.2 Factors Limiting Growth
5.2.1 Lower Prices
5.2.2 Administration/reimbursement
5.2.3 Infectious Disease is Declining But.
5.2.4 Wellness Hurts
5.2.5 Economic Growth improves Living Standards.
5.2.6 Impact of the Pandemic Recession
5.3 Instrumentation and Automation
5.3.1 Instruments Key to Market Share
5.3.2 The Shrinking Machine
5.3.3 Syndrome Testing Moving to Big Instruments?
5.4 Diagnostic Technology Development
5.4.1 Syndromictrends.com
5.4.2 Comparing Syndrome and Targeted Testing
5.4.3 The Multiplex Paradigm Shift
5.4.4 The Sepsis Testing Market - Bellwether for Syndromics
5.4.5 The Single Visit and Antimicrobial Resistance
5.4.6 Syndromics drives POCT adoption
5.4.7 A Big Future for PCR?

6 Syndromic Testing Recent Developments
6.1 Recent Developments - Importance and How to Use This Section

7 Profiles of Key Syndromic Testing Companies

8 The Global Market for Syndromic Multiplex Diagnostics

9 Global Syndromic Multiplex Markets - By Syndrome
9.1 Respiratory
9.2 Gastrointestinal
9.3 Blood
9.4 Meningitis/Encephalitis
9.5 Sexually Transmitted Disease
9.6 Other Syndrome

10 Global MDx Infectious Disease Markets - by Place
10.1 Hospital Lab
10.2 Outpatient Lab
10.3 Point of Care
10.4 Other Place

11 Global MDx Infectious Disease Markets - by Product
11.1 Instruments
11.2 Cartridges
11.3 Reagents
11.4 Other Product

12 Appendices

Companies Mentioned

Abacus Diagnostica
Abbott Diagnostics
Accelerate Diagnostics
Ador Diagnostics
Akonni Biosystems
Alveo Technologies
Antelope Dx
Applied BioCode
Aus Diagnostics
Baebies
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Binx Health
Biocartis
BioFire Diagnostics (bioMerieux)
bioMerieux Diagnostics
Bio-Rad Laboratories, Inc
Bosch Healthcare Solutions GmbH
Cepheid (Danaher)
Credo Diagnostics Biomedical
Cue Health
Curetis N.V./Curetis GmbH
Diagenode Diagnostics
Diasorin S.p.A
Enzo Life Sciences, Inc
Eurofins Scientific
Fluxergy
Fusion Genomics
Genetic Signatures
GenMark Dx (Roche)
Hibergene Diagnostics
Hologic
Immunexpress
Inflammatix
Invetech
Janssen Diagnostics
Karius
Lexagene
LightDeck Diagnostics
Lucira Health
Luminex Corp
Maxim Biomedical
Meridian Bioscience
Mesa Biotech (Thermo Fisher)
Millipore Sigma
Mobidiag (Hologic)
Molbio Diagnostics
Nanomix
Novel Microdevices
Operon
Oxford Nanopore Technologies
Panagene
Perkin Elmer
Primerdesign (Novacyt)
Prominex
Qiagen Gmbh
Quantumdx
Quidel
Roche Molecular Diagnostics
Saw Diagnostics
Seegene
Siemens Healthineers
Sona Nanotech
SpeeDx
T2 Biosystems
Talis Biomedical
Thermo Fisher Scientific Inc
Veramarx
Visby Medical
XCR Diagnostics

For more information about this report visit https://www.researchandmarkets.com/r/txo2bz

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets